Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Peake

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|June 21, 2011
A deadly cargoSimon William Dubrey, Simon Peake
AIDS (London, England)|November 6, 2019
Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infectionJohn P Thornhill, Kate D Lynch, Jessica K Skelton, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 2, 2021
Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitisAyesha Akbar, Ian Arnott, Nicholas A Kennedy, et al.
Mucosal Immunology|June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotypeJohn P Thornhill, Matthew Pace, Genevieve E Martin, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|June 21, 2011
A deadly cargoSimon William Dubrey, Simon Peake
AIDS (London, England)|November 6, 2019
Vedolizumab use and the associations between α4β7 expression and HIV reservoir in the gut during treated primary HIV infectionJohn P Thornhill, Kate D Lynch, Jessica K Skelton, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 2, 2021
Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitisAyesha Akbar, Ian Arnott, Nicholas A Kennedy, et al.
Mucosal Immunology|June 27, 2019
CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotypeJohn P Thornhill, Matthew Pace, Genevieve E Martin, et al.
Frontline Gastroenterology|September 2, 2022
Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumabCharles Miller, Hanson Kwok, Paul Harrow, et al.
Pageof 1